Solarvest Bioenergy Inc

Solarvest Bioenergy Inc

  • Price (EUR)0.049
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-72.93%
  • Beta--
Data delayed at least 15 minutes, as of Jun 27 2022 08:16 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Solarvest BioEnergy Inc. is a Canada-based algae biologics company. The principal business of the Company is the development of its algae-based production systems to develop and commercialize human health products and clean energy. The Company through has its subsidiary developed an algae-based production platform, which is capable of producing various products from Omega 3 fatty acids to human therapeutic proteins. The Company has developed its plant-based organic Omega 3 fatty acids that are rich in Docosahexaenoic Acid/ Eicosapentaenoic Acid (DHA/EPA). Its solar harvesting technology uses the sun, algae, and water to produce clean fuel with no carbon dioxide (CO2) footprint. It has also initiated a program for the expression of cannabidiol (CBD) and tetrahydrocannabinol (THC) to be produced in good manufacturing practices (GMP) fermentation facilities. Its subsidiaries include Phycobiologics (Europe) Limited, Eversea America Inc., and Eversea Inc.

  • Revenue in CAD (TTM)104.82k
  • Net income in CAD-2.51m
  • Incorporated2005
  • Employees--
  • Location
    Solarvest Bioenergy Inc439 Helmcken StreetVANCOUVER V6B2E6CanadaCAN
  • Phone+1 (416) 420-0947
  • Fax+1 (604) 684-3323
  • Websitehttp://www.solarvest.ca/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.